Keywords: IFPMA, Clinical trials, Transparency

New joint industry transparency position requires companies to disclose all clinical trials in patients

Article | 11 November 2009

The Council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has approved an updated Joint Position on the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eisai

Go to company listing